GE HealthCare Technologies Inc. $GEHC Stock Position Raised by AMG National Trust Bank

Posted by Francis Steltz on Jul 15th, 2026

AMG National Trust Bank raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 103.2% in the first quarter, Holdings Channel.com reports. The fund owned 26,910 shares of the company’s stock after acquiring an additional 13,670 shares during the quarter. AMG National Trust Bank’s holdings in GE HealthCare Technologies were worth $1,915,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the business. Laurel Wealth Advisors LLC bought a new position in shares of GE HealthCare Technologies in the fourth quarter worth about $26,000. Optima Capital LLC bought a new stake in GE HealthCare Technologies during the 4th quarter valued at approximately $27,000. Godfrey Financial Associates Inc. acquired a new stake in GE HealthCare Technologies in the 4th quarter valued at approximately $27,000. Montag A & Associates Inc. grew its holdings in GE HealthCare Technologies by 105.4% in the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 175 shares during the last quarter. Finally, Transamerica Financial Advisors LLC increased its position in GE HealthCare Technologies by 331.6% in the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after buying an additional 262 shares during the period. 82.06% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, Director Kevin Lobo bought 10,000 shares of the company’s stock in a transaction dated Friday, May 22nd. The stock was acquired at an average cost of $64.18 per share, with a total value of $641,800.00. Following the acquisition, the director owned 14,363 shares in the company, valued at approximately $921,817.34. This represents a 229.20% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO James Saccaro bought 3,310 shares of the business’s stock in a transaction that occurred on Friday, May 1st. The shares were bought at an average price of $60.60 per share, with a total value of $200,586.00. Following the transaction, the chief financial officer directly owned 87,471 shares in the company, valued at $5,300,742.60. This trade represents a 3.93% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders purchased 21,847 shares of company stock worth $1,361,355. Insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $61.66 on Wednesday. The company has a 50-day moving average of $63.54 and a 200-day moving average of $72.29. The company has a market capitalization of $28.05 billion, a price-to-earnings ratio of 14.75, a PEG ratio of 1.78 and a beta of 0.72. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same period in the previous year, the firm earned $1.01 EPS. The business’s revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s payout ratio is presently 3.35%.

Analysts Set New Price Targets

Several equities analysts recently commented on GEHC shares. Evercore set a $80.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Oppenheimer restated an “outperform” rating and set a $85.00 price objective on shares of GE HealthCare Technologies in a report on Thursday, April 30th. The Goldman Sachs Group reaffirmed a “neutral” rating on shares of GE HealthCare Technologies in a research report on Monday, June 8th. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, March 21st. Finally, Wells Fargo & Company decreased their target price on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a research report on Thursday, April 30th. Ten equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and a consensus price target of $79.48.

Check Out Our Latest Research Report on GEHC

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.